Skip to main content
. 2019 Sep 27;20(19):4812. doi: 10.3390/ijms20194812

Figure 7.

Figure 7

The ubiquitination of HER2 was increased in response to bortezomib. BT474 and SkBr3 cells were treated with 0.1 μM bortezomib for 24 h. HER2 then was immunoprecipitated for detection of protein ubiquitination with anti-ubiquitin antibody.